John Libbey Eurotext

European Journal of Dermatology


Journal Club: Cutaneous squamous cell carcinoma Volume 32, issue 5, September-October 2022

1 Department of Dermatology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
2 CIRI, Centre International de Recherche en Infectiologie, (Team Epidermal Immunity and Allergy); INSERM, U1111; Univ Lyon; Université de Lyon 1; Ecole Normale Supérieure de Lyon; CNRS, UMR 5308, Lyon, France
3 Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
4 Department of Dermatology, Cambridge University Hospitals, Addenbrookes Hospital, Cambridge, UK
5 Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, Portugal
6 Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Cutaneous squamous cell carcinoma (SCC) is one of the most frequent tumours in the world population [1]. It accounts for approximately 20-50% of skin cancers [2]. The worldwide incidence is increasing, probably in the context of increased exposure to ultraviolet radiation [3], as daily and continuous exposure to the sun has been shown to increase the risk of SCC [4].Most of these tumours have a good prognosis. Radical surgical excision leads to cure in most cases. However, there is a small group [...]